Safety of osteoanabolic therapy: A decade of experience

Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials

(2012) S.-L. Han et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years

(2012) Elizabeth B Andrews et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis

(2012) Mohammad Hassan Murad et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Osteosarcoma in Sprague-Dawley rats after long-term treatment with teriparatide (human parathyroid hormone (1-34))

(2012) Atsushi Watanabe et al.   JOURNAL OF TOXICOLOGICAL SCIENCES

Parathyroid Hormone 1-84 Accelerates Fracture-Healing in Pubic Bones of Elderly Osteoporotic Women

(2011) Peter Peichl et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: A randomized, placebo-controlled study

(2011) Tanja Sikjaer et al.   JOURNAL OF BONE AND MINERAL RESEARCH

PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism

(2011) Mishaela R Rubin et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical Femoral Fractures during Prolonged Use of Bisphosphonates: Short-Term Responses to Strontium Ranelate and Teriparatide

(2011) N. N. C. Carvalho et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Synthetic Human Parathyroid Hormone 1-34 Replacement Therapy: A Randomized Crossover Trial Comparing PumpVersusInjections in the Treatment of Chronic Hypoparathyroidism

(2011) Karen K. Winer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Parathyroid Hormone and Bone Healing

(2010) M. Ellegaard et al.   CALCIFIED TISSUE INTERNATIONAL

Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis

(2010) Julie Satterwhite et al.   CALCIFIED TISSUE INTERNATIONAL

Treatment of postmenopausal women with osteoporosis with PTH(1–84) for 36 months: treatment extension study

(2010) José R. Zanchetta et al.   CURRENT MEDICAL RESEARCH AND OPINION

Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D

(2010) David M. Slovik et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis

(2010) Joel S. Finkelstein et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Therapy of hypoparathyroidism with intact parathyroid hormone

(2010) M. R. Rubin et al.   OSTEOPOROSIS INTERNATIONAL

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial

(2009) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)

(2009) Bente L. Langdahl et al.   CALCIFIED TISSUE INTERNATIONAL

T Lymphocytes Amplify the Anabolic Activity of Parathyroid Hormone through Wnt10b Signaling

(2009) Masakazu Terauchi et al.   Cell Metabolism

International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons

(2009) Lisa Mirabello et al.   INTERNATIONAL JOURNAL OF CANCER

Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures

(2009) Per Aspenberg et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Resolution of Osteonecrosis of the Jaw After Teriparatide [Recombinant Human PTH-(1-34)] Therapy

(2009) A. N. LAU et al.   JOURNAL OF RHEUMATOLOGY

Of mice and men: divergent risks of teriparatide-induced osteosarcoma

(2009) V. Subbiah et al.   OSTEOPOROSIS INTERNATIONAL

Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1–84

(2008) R.R. Recker et al.   BONE

Parathyroid Hormone(1–84) Treatment of Postmenopausal Women with Low Bone Mass Receiving Hormone Replacement Therapy

(2008) I. Fogelman et al.   CALCIFIED TISSUE INTERNATIONAL

On the Interpretation of Rat Carcinogenicity Studies for Human PTH(1-34) and Human PTH(1-84)

(2008) Armen H Tashjian et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Lack of Bone Neoplasms and Persistence of Bone Efficacy in Cynomolgus Macaques After Long-Term Treatment With Teriparatide [rhPTH(1-34)]*

(2008) John L Vahle et al.   JOURNAL OF BONE AND MINERAL RESEARCH

PTH(1-34) Replacement Therapy in a Child With Hypoparathyroidism Caused by a Sporadic Calcium Receptor Mutation

(2008) Todd A Theman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Persistence with teriparatide in postmenopausal osteoporosis; impact of a patient education and follow-up program: the French experience

(2008) K. Briot et al.   OSTEOPOROSIS INTERNATIONAL

Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

(2008) R. Lindsay et al.   OSTEOPOROSIS INTERNATIONAL

Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window

(2008) John P. Bilezikian   Current Osteoporosis Reports